Cargando…
Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer
Endometrial cancer, the most common gynecologic malignancy, is a hormonally-regulated disease. Response to progestin therapy positively correlates with hormone receptor expression, in particular progesterone receptor (PR). However, many advanced tumors lose PR expression. We recently reported that t...
Autores principales: | Kavlashvili, Tamar, Jia, Yichen, Dai, Donghai, Meng, Xiangbing, Thiel, Kristina W., Leslie, Kimberly K., Yang, Shujie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747472/ https://www.ncbi.nlm.nih.gov/pubmed/26859414 http://dx.doi.org/10.1371/journal.pone.0148912 |
Ejemplares similares
-
Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer
por: Yang, Shujie, et al.
Publicado: (2014) -
miR-888: A Novel Cancer-Testis Antigen that Targets the Progesterone Receptor in Endometrial Cancer()()
por: Hovey, Adriann M., et al.
Publicado: (2015) -
Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer
por: Li, Yiyang, et al.
Publicado: (2022) -
Knockdown of MTDH Sensitizes Endometrial Cancer Cells to Cell Death Induction by Death Receptor Ligand TRAIL and HDAC Inhibitor LBH589 Co-Treatment
por: Meng, Xiangbing, et al.
Publicado: (2011) -
Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53
por: Meng, Xiangbing, et al.
Publicado: (2013)